Literature DB >> 9153558

Recognition of chlamydial antigen by HLA-B27-restricted cytotoxic T cells in HLA-B*2705 transgenic CBA (H-2k) mice.

W Kuon1, R Lauster, U Böttcher, A Koroknay, M Ulbrecht, M Hartmann, M Grolms, S Ugrinovic, J Braun, E H Weiss, J Sieper.   

Abstract

OBJECTIVE: The association of reactive arthritis (ReA) with HLA-B27 and the presence of bacterial antigen in joints with ReA suggest that bacterial peptides might be presented by the HLA-B27 molecule and thus stimulate CD8 T cells. This study was performed to investigate the B27-restricted cytotoxic T lymphocyte (CTL) response to Chlamydia trachomatis, using the model of HLA-B27 transgenic mice.
METHODS: CBA (H-2k) mice homozygous for HLA-B*2705 and human beta2-microglobulin expression were immunized with C trachomatis or with the chlamydial 57-kd heat-shock protein (hsp57) coupled to latex beads. Cytotoxicity of lymphocytes from in vivo-primed transgenic mice was tested against C trachomatis-infected targets. Blocking experiments were performed with monoclonal antibodies (MAb) against class I major histocompatibility complex molecules.
RESULTS: A Chlamydia-specific lysis of both B27-transfected and nontransfected target cells was observed. This response could be inhibited by anti-B27 and anti-H2 MAb. CTL from mice immunized with hsp57 were not able to lyse Chlamydia-infected target cells, and Chlamydia-specific CTL could not destroy targets loaded with hsp57.
CONCLUSION: These results suggest the existence of at least 2 CTL populations in this mouse model: one recognizing peptide of bacteria-infected cells restricted by HLA-B*2705 and the other recognizing peptide of bacteria-infected cells restricted by the murine H-2Kk molecule. It does not appear that hsp57 is a major target for the CD8 T cell response directed against Chlamydia. This animal model opens the way for identifying bacterial epitopes presented by HLA-B27, and might thus help to clarify the pathogenesis of B27-associated diseases.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9153558     DOI: 10.1002/art.1780400524

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  8 in total

1.  Animal models of the spondyloarthropathies.

Authors:  M Breban; G Falgarone; H Blanchard; E Dernis-Labous; D Lamarque
Journal:  Curr Rheumatol Rep       Date:  2000-08       Impact factor: 4.592

2.  Enhanced Direct Major Histocompatibility Complex Class I Self-Antigen Presentation Induced by Chlamydia Infection.

Authors:  Erik D Cram; Ryan S Simmons; Amy L Palmer; William H Hildebrand; Daniel D Rockey; Brian P Dolan
Journal:  Infect Immun       Date:  2015-11-23       Impact factor: 3.441

3.  Failure to detect HLA-A*6802-restricted CD8+ T cells specific for Chlamydia trachomatis antigens in subjects from trachoma-endemic communities.

Authors:  O S Mahdi; H C Whittle; H Joof; D C Mabey; R L Bailey
Journal:  Clin Exp Immunol       Date:  2001-01       Impact factor: 4.330

Review 4.  A molecular insight on the association of HLA-B27 with spondyloarthropathies.

Authors:  M Martí; I Alvarez; J A López de Castro
Journal:  Curr Rheumatol Rep       Date:  1999-10       Impact factor: 4.592

5.  Alteration of HLA-B27 peptide presentation after infection of transfected murine L cells by Shigella flexneri.

Authors:  F Boisgérault; J Mounier; V Tieng; M C Stolzenberg; I Khalil-Daher; M Schmid; P Sansonetti; D Charron; A Toubert
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

6.  Chlamydia trachomatis-specific human CD8+ T cells show two patterns of antigen recognition.

Authors:  Malgosia K Matyszak; J S Hill Gaston
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

7.  Major histocompatibility complex class I-restricted alloreactive CD4+ T cells.

Authors:  Louise H Boyle; Jane C Goodall; J S Hill Gaston
Journal:  Immunology       Date:  2004-05       Impact factor: 7.397

8.  Limitations of HLA-transgenic mice in presentation of HLA-restricted cytotoxic T-cell epitopes from endogenously processed human papillomavirus type 16 E7 protein.

Authors:  Michael D Street; Tracy Doan; Karen A Herd; Robert W Tindle
Journal:  Immunology       Date:  2002-08       Impact factor: 7.397

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.